The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis
New strategies for improving the efficacy of HIV vaccines are of significant importance. In this study, we analyzed the effect of deletion of the hypervariable V3 loop of gp120 on envelope (env)-specific CTL responses in PBMC of HIV-infected individuals. We showed increased CTL activities against co...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 1998-06, Vol.160 (11), p.5676-5683 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5683 |
---|---|
container_issue | 11 |
container_start_page | 5676 |
container_title | The Journal of immunology (1950) |
container_volume | 160 |
creator | Kmieciak, Dariusz Wasik, Thomas J Teppler, Hedy Pientka, Janet Hsu, Susan H Takahashi, Hidemi Okumura, Ko Kaneko, Yutaro Kozbor, Danuta |
description | New strategies for improving the efficacy of HIV vaccines are of significant importance. In this study, we analyzed the effect of deletion of the hypervariable V3 loop of gp120 on envelope (env)-specific CTL responses in PBMC of HIV-infected individuals. We showed increased CTL activities against conserved epitopes of the env glycoprotein in cultures induced with the AV3 mutant compared with those stimulated with the full-length env gene products. In contrast to the wild-type env, the AV3 mutant-expressing cells were resistant to Ab-dependent cell-mediated cytotoxicity, formed no syncytia, and neither underwent nor induced apoptosis in CD4+ cells. Thus, the AV3 mutant may redirect immune responses toward conserved epitopes of gp160, has longer expression time due to increased resistance to Ab-dependent cell-mediated cytotoxicity, and does not trigger cytopathic effects associated with apoptosis and syncytium formation. This approach may apply to other Ags of HIV, where deletions of highly variable or immunosuppressive epitopes may improve the efficacy of HIV vaccines. |
doi_str_mv | 10.4049/jimmunol.160.11.5676 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16427039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16427039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-c4498c0edd60400921f8641def721b13c7ab064dce17b36ff5d366d53836fe453</originalsourceid><addsrcrecordid>eNpNUE1P4zAQtdAi6AL_ACSfVlxSZhLHaY6owIJUBEKFq5XG49YoiUPsqvDv11W7iMvMPL0PjR5j5whjAaK8erdtu-5cM0YJY8RxLgt5wEaY55BICfIXGwGkaYKFLI7Zb-_fAUBCKo7YUSkhxyIfsX6-In5rDNWBO8NvqKFgXbe9Q2TeMj5zrt_CZY8p8EhNv4IL7tPWfM6n1DT8hXzvOk-eV53m9w9vO23ySNpWgTR_rsLKLakjb_0pOzRV4-lsv0_Y693tfHqfzJ7-PkyvZ0ktMA1xinJSA2ktQQCUKZqJFKjJFCkuMKuLagFS6JqwWGTSmFxnUuo8m0RAIs9O2J9dbj-4jzX5oFrr6_hu1ZFbe4VSpAVkZRSKnbAenPcDGdUPtq2GL4WgtkWr_0VHDyhEtS062i72-etFS_rbtG828pc7fmWXq40dSPm2apqoRrXZbH5G_QMGp4dv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16427039</pqid></control><display><type>article</type><title>The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Kmieciak, Dariusz ; Wasik, Thomas J ; Teppler, Hedy ; Pientka, Janet ; Hsu, Susan H ; Takahashi, Hidemi ; Okumura, Ko ; Kaneko, Yutaro ; Kozbor, Danuta</creator><creatorcontrib>Kmieciak, Dariusz ; Wasik, Thomas J ; Teppler, Hedy ; Pientka, Janet ; Hsu, Susan H ; Takahashi, Hidemi ; Okumura, Ko ; Kaneko, Yutaro ; Kozbor, Danuta</creatorcontrib><description>New strategies for improving the efficacy of HIV vaccines are of significant importance. In this study, we analyzed the effect of deletion of the hypervariable V3 loop of gp120 on envelope (env)-specific CTL responses in PBMC of HIV-infected individuals. We showed increased CTL activities against conserved epitopes of the env glycoprotein in cultures induced with the AV3 mutant compared with those stimulated with the full-length env gene products. In contrast to the wild-type env, the AV3 mutant-expressing cells were resistant to Ab-dependent cell-mediated cytotoxicity, formed no syncytia, and neither underwent nor induced apoptosis in CD4+ cells. Thus, the AV3 mutant may redirect immune responses toward conserved epitopes of gp160, has longer expression time due to increased resistance to Ab-dependent cell-mediated cytotoxicity, and does not trigger cytopathic effects associated with apoptosis and syncytium formation. This approach may apply to other Ags of HIV, where deletions of highly variable or immunosuppressive epitopes may improve the efficacy of HIV vaccines.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.160.11.5676</identifier><identifier>PMID: 9605175</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Adult ; Antibody-Dependent Cell Cytotoxicity - genetics ; Apoptosis - genetics ; Apoptosis - immunology ; Cell Line, Transformed ; Gene Products, env - biosynthesis ; Gene Products, env - genetics ; Giant Cells - immunology ; Giant Cells - virology ; HIV Envelope Protein gp120 - genetics ; HIV Envelope Protein gp120 - physiology ; HIV Infections - etiology ; HIV Infections - immunology ; Humans ; Leukocytes, Mononuclear - immunology ; Mutagenesis, Site-Directed ; Sequence Deletion ; T-Lymphocytes, Cytotoxic - immunology ; Vaccinia virus - genetics</subject><ispartof>The Journal of immunology (1950), 1998-06, Vol.160 (11), p.5676-5683</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-c4498c0edd60400921f8641def721b13c7ab064dce17b36ff5d366d53836fe453</citedby><cites>FETCH-LOGICAL-c412t-c4498c0edd60400921f8641def721b13c7ab064dce17b36ff5d366d53836fe453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9605175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kmieciak, Dariusz</creatorcontrib><creatorcontrib>Wasik, Thomas J</creatorcontrib><creatorcontrib>Teppler, Hedy</creatorcontrib><creatorcontrib>Pientka, Janet</creatorcontrib><creatorcontrib>Hsu, Susan H</creatorcontrib><creatorcontrib>Takahashi, Hidemi</creatorcontrib><creatorcontrib>Okumura, Ko</creatorcontrib><creatorcontrib>Kaneko, Yutaro</creatorcontrib><creatorcontrib>Kozbor, Danuta</creatorcontrib><title>The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>New strategies for improving the efficacy of HIV vaccines are of significant importance. In this study, we analyzed the effect of deletion of the hypervariable V3 loop of gp120 on envelope (env)-specific CTL responses in PBMC of HIV-infected individuals. We showed increased CTL activities against conserved epitopes of the env glycoprotein in cultures induced with the AV3 mutant compared with those stimulated with the full-length env gene products. In contrast to the wild-type env, the AV3 mutant-expressing cells were resistant to Ab-dependent cell-mediated cytotoxicity, formed no syncytia, and neither underwent nor induced apoptosis in CD4+ cells. Thus, the AV3 mutant may redirect immune responses toward conserved epitopes of gp160, has longer expression time due to increased resistance to Ab-dependent cell-mediated cytotoxicity, and does not trigger cytopathic effects associated with apoptosis and syncytium formation. This approach may apply to other Ags of HIV, where deletions of highly variable or immunosuppressive epitopes may improve the efficacy of HIV vaccines.</description><subject>Adult</subject><subject>Antibody-Dependent Cell Cytotoxicity - genetics</subject><subject>Apoptosis - genetics</subject><subject>Apoptosis - immunology</subject><subject>Cell Line, Transformed</subject><subject>Gene Products, env - biosynthesis</subject><subject>Gene Products, env - genetics</subject><subject>Giant Cells - immunology</subject><subject>Giant Cells - virology</subject><subject>HIV Envelope Protein gp120 - genetics</subject><subject>HIV Envelope Protein gp120 - physiology</subject><subject>HIV Infections - etiology</subject><subject>HIV Infections - immunology</subject><subject>Humans</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Mutagenesis, Site-Directed</subject><subject>Sequence Deletion</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Vaccinia virus - genetics</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUE1P4zAQtdAi6AL_ACSfVlxSZhLHaY6owIJUBEKFq5XG49YoiUPsqvDv11W7iMvMPL0PjR5j5whjAaK8erdtu-5cM0YJY8RxLgt5wEaY55BICfIXGwGkaYKFLI7Zb-_fAUBCKo7YUSkhxyIfsX6-In5rDNWBO8NvqKFgXbe9Q2TeMj5zrt_CZY8p8EhNv4IL7tPWfM6n1DT8hXzvOk-eV53m9w9vO23ySNpWgTR_rsLKLakjb_0pOzRV4-lsv0_Y693tfHqfzJ7-PkyvZ0ktMA1xinJSA2ktQQCUKZqJFKjJFCkuMKuLagFS6JqwWGTSmFxnUuo8m0RAIs9O2J9dbj-4jzX5oFrr6_hu1ZFbe4VSpAVkZRSKnbAenPcDGdUPtq2GL4WgtkWr_0VHDyhEtS062i72-etFS_rbtG828pc7fmWXq40dSPm2apqoRrXZbH5G_QMGp4dv</recordid><startdate>19980601</startdate><enddate>19980601</enddate><creator>Kmieciak, Dariusz</creator><creator>Wasik, Thomas J</creator><creator>Teppler, Hedy</creator><creator>Pientka, Janet</creator><creator>Hsu, Susan H</creator><creator>Takahashi, Hidemi</creator><creator>Okumura, Ko</creator><creator>Kaneko, Yutaro</creator><creator>Kozbor, Danuta</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19980601</creationdate><title>The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis</title><author>Kmieciak, Dariusz ; Wasik, Thomas J ; Teppler, Hedy ; Pientka, Janet ; Hsu, Susan H ; Takahashi, Hidemi ; Okumura, Ko ; Kaneko, Yutaro ; Kozbor, Danuta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-c4498c0edd60400921f8641def721b13c7ab064dce17b36ff5d366d53836fe453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Antibody-Dependent Cell Cytotoxicity - genetics</topic><topic>Apoptosis - genetics</topic><topic>Apoptosis - immunology</topic><topic>Cell Line, Transformed</topic><topic>Gene Products, env - biosynthesis</topic><topic>Gene Products, env - genetics</topic><topic>Giant Cells - immunology</topic><topic>Giant Cells - virology</topic><topic>HIV Envelope Protein gp120 - genetics</topic><topic>HIV Envelope Protein gp120 - physiology</topic><topic>HIV Infections - etiology</topic><topic>HIV Infections - immunology</topic><topic>Humans</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Mutagenesis, Site-Directed</topic><topic>Sequence Deletion</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Vaccinia virus - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kmieciak, Dariusz</creatorcontrib><creatorcontrib>Wasik, Thomas J</creatorcontrib><creatorcontrib>Teppler, Hedy</creatorcontrib><creatorcontrib>Pientka, Janet</creatorcontrib><creatorcontrib>Hsu, Susan H</creatorcontrib><creatorcontrib>Takahashi, Hidemi</creatorcontrib><creatorcontrib>Okumura, Ko</creatorcontrib><creatorcontrib>Kaneko, Yutaro</creatorcontrib><creatorcontrib>Kozbor, Danuta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kmieciak, Dariusz</au><au>Wasik, Thomas J</au><au>Teppler, Hedy</au><au>Pientka, Janet</au><au>Hsu, Susan H</au><au>Takahashi, Hidemi</au><au>Okumura, Ko</au><au>Kaneko, Yutaro</au><au>Kozbor, Danuta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1998-06-01</date><risdate>1998</risdate><volume>160</volume><issue>11</issue><spage>5676</spage><epage>5683</epage><pages>5676-5683</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>New strategies for improving the efficacy of HIV vaccines are of significant importance. In this study, we analyzed the effect of deletion of the hypervariable V3 loop of gp120 on envelope (env)-specific CTL responses in PBMC of HIV-infected individuals. We showed increased CTL activities against conserved epitopes of the env glycoprotein in cultures induced with the AV3 mutant compared with those stimulated with the full-length env gene products. In contrast to the wild-type env, the AV3 mutant-expressing cells were resistant to Ab-dependent cell-mediated cytotoxicity, formed no syncytia, and neither underwent nor induced apoptosis in CD4+ cells. Thus, the AV3 mutant may redirect immune responses toward conserved epitopes of gp160, has longer expression time due to increased resistance to Ab-dependent cell-mediated cytotoxicity, and does not trigger cytopathic effects associated with apoptosis and syncytium formation. This approach may apply to other Ags of HIV, where deletions of highly variable or immunosuppressive epitopes may improve the efficacy of HIV vaccines.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>9605175</pmid><doi>10.4049/jimmunol.160.11.5676</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 1998-06, Vol.160 (11), p.5676-5683 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_16427039 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Adult Antibody-Dependent Cell Cytotoxicity - genetics Apoptosis - genetics Apoptosis - immunology Cell Line, Transformed Gene Products, env - biosynthesis Gene Products, env - genetics Giant Cells - immunology Giant Cells - virology HIV Envelope Protein gp120 - genetics HIV Envelope Protein gp120 - physiology HIV Infections - etiology HIV Infections - immunology Humans Leukocytes, Mononuclear - immunology Mutagenesis, Site-Directed Sequence Deletion T-Lymphocytes, Cytotoxic - immunology Vaccinia virus - genetics |
title | The Effect of Deletion of the V3 Loop of gp120 on Cytotoxic T Cell Responses and HIV gp120-Mediated Pathogenesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A06%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Deletion%20of%20the%20V3%20Loop%20of%20gp120%20on%20Cytotoxic%20T%20Cell%20Responses%20and%20HIV%20gp120-Mediated%20Pathogenesis&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Kmieciak,%20Dariusz&rft.date=1998-06-01&rft.volume=160&rft.issue=11&rft.spage=5676&rft.epage=5683&rft.pages=5676-5683&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.160.11.5676&rft_dat=%3Cproquest_cross%3E16427039%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16427039&rft_id=info:pmid/9605175&rfr_iscdi=true |